EMAIL THIS PAGE TO A FRIEND

The Journal of pharmacology and experimental therapeutics

TRV0109101, a G Protein-Biased Agonist of the


PMID 28533287

Abstract

Prescription opioids are a mainstay in the treatment of acute moderate to severe pain. However, chronic use leads to a host of adverse consequences including tolerance and opioid-induced hyperalgesia (OIH), leading to more complex treatment regimens and diminished patient compliance. Patients with OIH paradoxically experience exaggerated nociceptive responses instead of pain reduction after chronic opioid usage. The development of OIH and tolerance tend to occur simultaneously and, thus, present a challenge when studying the molecular mechanisms driving each phenomenon. We tested the hypothesis that a G protein-biased

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

N3290
NKH 477, ≥98% (HPLC), powder
C27H43NO8·HCl